Concepedia

Christopher H. Crane

CH

237

Publications

25.2K

Citations

79

H-Index

1962

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

Radiation Oncology Associates

NRG Oncology

University of Maryland, Baltimore

Christopher H. Crane is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1962–2024

237

Publications

237

PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

Andrea Cercek, Melissa Lumish, Jenna Sinopoli et al. · New England Journal of Medicine · 2022 · 1.4K citations · Full text

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

Patrick J. Loehrer, Yang Feng, Higinia R. Cárdenes et al. · Journal of Clinical Oncology · 2011 · 817 citations

Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

Matthew H. G. Katz, Peter W. T. Pisters, Douglas B. Evans et al. · Journal of the American College of Surgeons · 2008 · 813 citations · Full text

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

Douglas B. Evans, Gauri R. Varadhachary, Christopher H. Crane et al. · Journal of Clinical Oncology · 2008 · 726 citations

Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Andrea Cercek, Campbell S.D. Roxburgh, Paul Strombom et al. · JAMA Oncology · 2018 · 615 citations · Full text

Rows per page

1–5 of 237